Jorge Berlanga‐Acosta

Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure

J. Fernández-Montequín, Luis H Martinez, E. L. Mola, 2009, International wound journal.